Allergy Diagnostics Market Size, Share, Growth | Forecast 2022-2030

The global Allergy Diagnostics market gathered revenue around USD 4.0 Billion in 2020 and market is set to grow USD 10.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 12% during the prediction period 2021 to 2027.

Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/5782

The high incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, increasing funds by organizations in allergy diagnostics, and the increasing access to healthcare insurance.

Food allergy is a growing health concern, with increasing prevalence in both developed and developing countries. According to a research study by Wenyin Loh et al., published in the International Journal of Environmental Research and Public Health, September 2018, in developed countries, food allergy has been reported to be as high as 10%, with the most prevalence witnessed among younger children. Moreover, there is an increasing prevalence of food allergies in developing countries; China and Africa are similar to developed countries in terms of the prevalence of allergies.

Therefore, with the growing burden of allergic diseases, the new diagnostic market for the same is expected to grow significantly. Furthermore, the latest diagnostic strategies for allergies and research on new treatment approaches are expected to drive the market studied over the forecast period. However, a lack of awareness about allergic diseases and affordability of allergy diagnostics are expected to restrain the market growth.

Report Coverage

The research provides a detailed segmentation of the global allergy diagnostics market based on test type, product & service, allergen, and end user, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.

Based on test type, the in vivo segment held the highest share in 2021, accounting for more than half of the global allergy diagnostics market, and is expected to continue its leadership status during the forecast period. However, the in vitro segment is expected to register the highest CAGR of 13.5% from 2022 to 2031.

Based on product & service, the consumables segment accounted for the highest share in 2021, contributing to around half of the global allergy diagnostics market, and is expected to maintain its lead in terms of revenue during the forecast period. Moreover, the same segment is expected to manifest the highest CAGR of 13.6% from 2022 to 2031.

Based on end user, the diagnostic laboratories segment accounted for the highest share in 2021, holding nearly half of the global allergy diagnostics market, and is expected to continue its leadership status during the forecast period. Moreover, the same segment is estimated to grow at the highest CAGR of 13.7% during the forecast period.

Based on region, North America held the largest share in 2021, contributing to around one-third of the total allergy diagnostics market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 14.2% during the forecast period. The research also analyzes regions including Europe and LAMEA.

Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/5782

Covid-19 Scenario:

• Due to the outbreak of the COVID-19 pandemic in 2020, there was a little slowdown in the market for allergy diagnostics, as diagnostic tests were being postponed due to lockdown scenarios.
• However, in 2021, the diagnostic processes resumed. To determine the impact of COVID-19 on allergy diagnostic testing services, several research had been done.
• According to a survey done in Turkey, allergists preferred telemedicine for treating asthma and rhinitis at a high rate. For more serious allergic conditions, such as anaphylaxis and hereditary angioedema, face-to-face interviews were recommended.
• Other nations such as Italy and the U.S. also showed a similar tendency. Australia reduced the number of outpatient clinic face-to-face consultations for urgent patients with rheumatological disorders and switched approximately 80% of outpatient visits to telemedicine.
• The expansion of the market was also constrained by this restriction and a decrease in different diagnostic and treatment services.

Some of the prominent players in the Allergy Diagnostics Market include: Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher, Omega Diagnostics Group PLC, bioMérieux SA, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, NEOGEN Corporation, Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, HOB Biotech Group Corp., Ltd., HYCOR Biomedical, R-Biopharm AG , AESKU.GROUP GmbH, ACON Laboratories, Inc.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Allergy Diagnostics Market by Product & Service

• Consumables
• Instruments
  • Immunoassay Analyzers
  • ELISA Analyzers
  • Luminometers
  • Other Instruments
• Services

Allergy Diagnostics Market by Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Allergy Diagnostics Market by Test Type

• In Vivo Tests
  • Skin Prick Tests
  • Patch Tests
  • Other In Vivo Tests
• In Vitro Tests

Allergy Diagnostics Market by End User

• Diagnostic Laboratories
• Hospital-based Laboratories
• Academic Research Institutes
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/5782

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

Blog: https://qyresearchmedical.com/